Growth Drivers for Biomarkers in Healthcare

Managing Success in the Biomarker Industry—Challenges and Opportunities

USD 2,450.00

* Required Fields

USD 2,450.00


Be the first to review this product

Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological platforms in biomarkers discovery, validation and development in the drug discovery and development market globally. The research study addresses the major issues and challenges, unmet needs and emerging market & technological trends. The report also outlines market drivers and restraints, recent research and developments, Key Innovations and Companies to watch etc.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Market OutlookNew Market OpportunitiesKey Innovations and Companies to WatchKey Innovations and Companies to Watch (continued)Key Innovations and Companies to Watch (continued)Recent Research and DevelopmentsMethodologyResearch ScopeMarket OverviewMarket Segmentation Market Segmentation (continued) Key Terminology Major Categories of BiomarkersMajor Categories of Biomarkers (continued)Significance of BiomarkersSignificance of Biomarkers (continued)Key Stakeholders in the Biomarkers IndustryBiomarkers Industry—Value-based EnvironmentRegulatory Landscape in the Companion Diagnostics and Biomarkers MarketDrivers and Restraints—Biomarkers IndustryChallenges in the Discovery of BiomarkersMarket DriversDrivers ExplainedDrivers Explained (continued)Market RestraintsRestraints ExplainedRestraints Explained (continued)Forecast and Trends—Total Biomarkers Market Revenue Forecast by TechnologyPer Cent Revenue Breakdown by TechnologyRevenue Forecast by Technology DiscussionRevenue Forecast by RegionPer Cent Revenue Breakdown by RegionRevenue Forecast by Region DiscussionTechnology Lifecycle AnalysisBiomarkers Industry Trends and Recent DevelopmentsMarket TrendsTechnology TrendsGenomics—Recent Developments and ApplicationsProteomics—Recent Developments and ApplicationsMetabolomics—Recent Developments and ApplicationsGlycomics—Recent Developments and ApplicationsLipidomics—Recent Developments and Applications‘Cross-omics’ Approach‘Omics’ and Personalised MedicineBiomarker—Discovery to Clinical UtilityUse of Validated BiomarkersConclusions and RecommendationsThree Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)The Last Word—Discussion (continued)Legal DisclaimerAppendixList of Other Companies in Biomarkers Research, Development, and/or ServicesList of Other Companies in Biomarkers Research, Development, and/or Services (continued)List of Other Companies in Biomarkers Research, Development, and/or Services (continued)List of ExhibitsList of Exhibits (continued)List of AbbreviationsThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.